An mRNA twist to the HIV vaccine problem
For decades, researchers have tried to craft a successful vaccine for HIV. mRNA vaccines may offer the answer.
vaccine
Oral vaccines: from mouth to mucosal immunity
Oral vaccines stop pathogens in their tracks before they get a chance to cause disease.
No need for a cold chain with these thin films
Most vaccines and biologics must stay cold until ready for use, but new thin film technology stabilizes these therapeutics for months at room temperature.
Better rabies treatments bite back
Symptomatic rabies has no cure, but recent advances in rabies structural biology and antibody cocktails point to better treatments on the horizon.
Origami vaccines fold up to fight cancer
As self-assembling structures, DNA and RNA origami vaccines hold vaccine components in precise numbers and arrangements to help the immune system attack tumors.
A New Era of Vaccine Development
Researchers investigate new approaches to revolutionizing vaccines for cancer and infectious diseases.
Mapping Nipah viral architecture to prevent a new pandemic
Researchers defined the structure of key Nipah virus proteins to develop vaccines and treatments for this deadly virus.
Strategies for Detecting New Viral Threats
Learn how scientists detect viral pathogens lurking in the environment to mitigate infectious disease threats.
The quest for a respiratory syncytial virus vaccine is almost complete
After tragedy struck during a 1960s clinical trial, development of a vaccine for RSV ground to a halt. But as new RSV vaccine candidates enter late-stage clinical trials, a safe and effective vaccine is finally in sight.
